Survey of Ophthalmology
Volume 45 , Pages S261-S267 , May 2001

Retinal Ganglion Cell Death Induced by Retinal Ischemia: Neuroprotective Effects of Two Alpha-2 Agonists

References 

  1. Cheng B, Mattson MP. NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis. Neuron. 1991;7:1031–1041
  2. Donello JE, Padillo E, Webster S. Brimonidine inhibits the vitreal accumulation of glutamate and aspartate in the retinal transient ischemia model. Invest Ophthalmol Vis Sci. 2000;41(Suppl):S831;[abstract]
  3. Freese A, Finklestein SP, DiFiglia M. Basic fibroblast growth factor protects striatal neurons in vitro from NMDA-receptor mediated excitotoxicity. Brain Res. 1992;575:351–355
  4. Gomez-Ramirez AM, Villegas-Perez MP, Miralles de Imperial J, et al.  Effects of intramuscular injection of botulinum toxin and doxorubicin on the survival of abducens motoneurons. Invest Ophthalmol Vis Sci. 1999;40:414–424
  5. Joo CK, Choi JS, Ko HW, et al.  Necrosis and apoptosis after retinal ischemia (involvement of NMDA-mediated excitotoxicity and p53). Invest Ophthalmol Vis Sci. 1999;40:713–720
  6. Kendell KR, Quigley HA, Kerrigan LA, et al.  Primary open-angle glaucoma is not associated with photoreceptor loss. Invest Ophthalmol Vis Sci. 1995;36:200–205
  7. Mattson MP, Murrain M, Guthrie PB, Kater SB. Fibroblast growth factor and glutamate (opposing roles in the generation and degeneration of hippocampal neuroarchitecture). J Neurosci. 1989;9:3728–3740
  8. Osborne NN, Ugarte M, Chao M, et al.  Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv Ophthalmol. 1999;43(Suppl 1):S102–S128
  9. Otori Y, Shimada S, Morimura H, et al.  Expression of c-fos and c-jun mRNA following transient retinal ischemia (an approach using ligation of the retinal central artery in the rat). Surv Ophthalmol. 1997;42(Suppl 1):S96–104
  10. Peinado-Ramon P, Salvador M, Villegas-Perez MP, Vidal-Sanz M. Effects of axotomy and intraocular administration of NT-4, NT-3, and brain-derived neurotrophic factor on the survival of adult rat retinal ganglion cells. A quantitative in vivo study. Invest Ophthalmol Vis Sci. 1996;37:489–500
  11. Robin AL. The role of alpha-agonists in glaucoma therapy. Curr Opin Ophthalmol. 1997;8:142–149
  12. Rosenbaum DM, Rosenbaum PS, Gupta A, et al.  Retinal ischemia leads to apoptosis which is ameliorated by aurintricarboxylic acid. Vision Res. 1997;37:3445–3451
  13. Salvador-Silva M, Vidal-Sanz M, Villegas-Perez MP. Microglial cells in the retina of Carassius auratus (effects of optic nerve crush). J Comp Neurol. 2000;417:431–447
  14. Selles-Navarro I, Villegas-Perez MP, Salvador-Silva M, et al.  Retinal ganglion cell death after different transient periods of pressure-induced ischemia and survival intervals. A quantitative in vivo study. Invest Ophthalmol Vis Sci. 1996;37:2002–2014
  15. Tatton W, Chalmers-Redman RME, Podos SM, Mittag TM. Maintaining mitochondrial membrane impermeability (An opportunity for new therapy in glaucoma?). Surv Ophthalmol. 2001;45(Suppl 3):S277–S283
  16. Unoki K, LaVail MM. Protection of the rat retina from ischemic injury by brain-derived neurotrophic factor, ciliary neurotrophic factor, and basic fibroblast growth factor. Invest Ophthalmol Vis Sci. 1994;35:907–915
  17. Vidal-Sanz M, Lafuente MP, Miralles de Imperial J, Villegas-Pérez MP. Long term effects of transient ischemia induced by selective ligature of the ophthalmic vessels on retinal ganglion cell survival. Invest Ophthalmol Vis Sci. 1999;40(Suppl):S480;[abstract]
  18. Vidal-Sanz M, Lafuente MP, Sobrado-Calvo P. Death and neuroprotection of retinal ganglion cells after different types of injury. Neurotoxicity Res. 2000;2:215–227
  19. Vidal-Sanz M, Villegas-Perez MP, Bray GM, Aguayo AJ. Persistent retrograde labeling of adult rat retinal ganglion cells with the carbocyanine dye diI. Exp Neurol. 1988;102:92–101
  20. Villegas-Perez MP, Vidal-Sanz M, Bray GM, Aguayo AJ. Influences of peripheral nerve grafts on the survival and regrowth of axotomized retinal ganglion cells in adult rats. J Neurosci. 1988;8:265–280
  21. Villegas-Perez MP, Vidal-Sanz M, Rasminsky M, et al.  Rapid and protracted phases of retinal ganglion cell loss follow axotomy in the optic nerve of adult rats. J Neurobiol. 1993;24:23–36
  22. Villegas-Pérez MP, Lafuente MP, Mayor-Torroglosa S. Effects of an alpha-2 agonist (AGN 190342, Brimonidine) on retinal ganglion cell survival after transient ischemia induced by selective ligature of the ophthalmic vessels. Ophthalmic Res. 2000;32:48;[abstract]
  23. Villegas-Pérez MP, Rodrı́guez ME, Garcı́a A. Transient ischemia of the retina (long-term neuroprotection of inner retinal layers with a selective alpha-2 agonist (AGN190342, Brimonidine)). Ophthalmic Res. 2000;32:48;[abstract]
  24. Walters TR. Development and use of brimonidine in treating acute and chronic elevations of intraocular pressure (a review of safety, efficacy, dose response, and dosing studies). Surv Ophthalmol. 1996;41(Suppl 1):S19–S26
  25. Wen R, Cheng T, Li Y, et al.  Alpha 2-adrenergic agonists induce basic fibroblast growth factor expression in photoreceptors in vivo and ameliorate light damage. J Neurosci. 1996;16:5986–5992
  26. Wheeler LA, Lai R, Woldemussie E. From the lab to the clinic (activation of an alpha-2 agonist pathway is neuroprotective in models of retinal and optic nerve injury). Eur J Ophthalmol. 1999;9(Suppl 1):S17–S21
  27. WoldeMussie E, Ruiz G, Wijono M, Wheeler LA. Neuroprotective effect of Brimonidine in chronic ocular hypertensive rats. Invest Ophthalmol Vis Sci. 2000;41(Suppl):S830;[abstract]
  28. Yoles E, Wheeler LA, Schwartz M. Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. Invest Ophthalmol Vis Sci. 1999;40:65–73[published erratum appears in Invest Ophthalmol Vis Sci 199 Oct;40(11):2470]
  29. Yoon YH, Marmor MF. Dextromethorphan protects retina against ischemic injury in vivo. Arch Ophthalmol. 1989;107:409–411
  30. Zhang C, Takahashi K, Lam TT, Tso MO. Effects of basic fibroblast growth factor in retinal ischemia. Invest Ophthalmol Vis Sci. 1994;35:3163–3168

PII: S0039-6257(01)00205-3

Survey of Ophthalmology
Volume 45 , Pages S261-S267 , May 2001

Article Tools

* Image Usage & Resolution